How many drugs treat Sarcoma of soft tissue?

Drug Landscape tracks 3 marketed treatments for Sarcoma of soft tissue (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/sarcoma-of-soft-tissue.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Sarcoma of soft tissue — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sarcoma of soft tissue (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Sarcoma of soft tissue, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Lartruvo	OLARATUMAB	Eli Lilly	Platelet-derived Growth Factor Receptor alpha Antagonist	Platelet-derived growth factor receptor alpha	2016-01-01
Beromun	TASONERMIN	Boehringer Ingelheim International GmbH			1999-01-01
Votrient	Votrient	Tracon Pharmaceuticals Inc.		Bone morphogenetic protein receptor type-1B, Cyclin-dependent kinase 11A, Cyclin-dependent kinase 11B

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Boehringer Ingelheim International GmbH · 1 drug in Sarcoma of soft tissue
Eli Lilly · 1 drug in Sarcoma of soft tissue
Tracon Pharmaceuticals Inc. · 1 drug in Sarcoma of soft tissue

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Sarcoma of soft tissue:

Cite this brief

Drug Landscape (2026). Sarcoma of soft tissue — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/sarcoma-of-soft-tissue. Accessed 2026-06-10.

Sarcoma of soft tissue full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing